Secondary Metabolites from Marine Molluscs: Chemistry, Biosynthesis, Synthesis and Bioactivity

Dear Colleagues,

The phylum Mollusca embraces a high diversity of species, which turned out to be of great interest to natural products chemists. Chemical studies unveiled a variety of unique scaffolds inspiring leading drugs currently in clinical trials. Thus, extending investigation on unexplored species is expected to reveal novel molecular architectures. Beyond the chemistry and pharmacological potential of molluscan metabolites, their crucial role in regulating chemo-ecological interactions has also been addressed. The majority of these molecules are obtained from food sources, but they can be biosynthesized de novo, or derived from symbiotic microorganisms.

This Special Issue is open to contributions covering all aspects of chemistry, chemical ecology and pharmacological potential of secondary metabolites from molluscs; papers are welcome reporting on: i) the discovery of novel bioactive compounds and their molecular targets; ii) the origin and the biosynthetic pathways by which these metabolites are produced; iii) their chemo-ecological role; iv) the synthetic strategies designed to overcome the supply issue for the metabolites themselves and to provide derivatives with improved potency.

Dr. Adele Cutignano
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.